Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Screening
Breast tumor size prediction methods were compared for accuracy
March 23rd, 2006
Physical examination, ultrasonography, and mammography were only moderately useful for predicting residual pathologic tumor size after neoadjuvant chemotherapy. A study published in the journal Annals of Surgery sought "to assess the accuracy of physical examination, ultrasonography, and mammography in predicting residual size of breast tumors following neoadjuvant chemotherapy. Neoadjuvant chemotherapy is an accepted part of the management of stage II and III breast cancer." "Accurate prediction of residual pathologic tumor size after neoadjuvant chemotherapy is critical in guiding surgical therapy," stated A.B. Chagpar and colleagues, M.D....
Source: Women's Health Weekly (2006-03-23)
|
